H.R. 2071
Referred to CommitteeMedicare Prescription Drug Price Negotiation Act of 2021
Introduced 3/18/2021•117th Congress•House
Latest Action
Referred to the Subcommittee on Health.
3/19/2021 • House
Summary
Medicare Prescription Drug Price Negotiation Act of 2021
This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.
Introduced in House • 3/18/2021
Enter your district to see how this bill affects your community
Topics & Subjects
Policy Area: Health
Health care costs and insuranceInflation and pricesMedicarePrescription drugsPublic contracts and procurement
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (13)
Party Breakdown
13
Democrats
0
Republicans
0
Independents
Sponsor
RL
Cosponsors (12)
R[
R[
R[
R[
R[
R[
Bill Journey
Originated in the House
Introduced
March 18, 2021
Referred to the Subcommittee on Health.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Introduced in House3/18/2021